Activity value 80International Buyer&Supplier,Last transaction date:
2026-07-05Address: p.o.box 65 fi-02101 espoo finland
Overview
Export data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for orion pharma from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 48 transactions, with a transaction quantity of 13968.24 and a transaction weight of 18705.16.
YearTransactionsQuantityWeight
2025130112136.4759376.05
20264813968.2418705.16
Bill of lading data
<
1/15
>
Trade date
2026/07/05
B/L No.
iglbmu32193hsnyc
Suppliers
orion pharma
Buyers
sun pharmaceutical industries ltd.
POLs
42305, anvers
PODs
4601, new york/newark area, newark, nj
orion pharma is International Buyer&Supplier,
and primarily engages in the import and export business of products such as western medicine,orion pharma,promotional item.
According to the 52wmb.com global trade database, as of 2026-07-05, the company has completed 2602 international trades,
with its main trading regions covering sri lanka,philippines,pakistan etc.
The core products include HS30049090,HS30049099,HS30042000 etc,
and its main trading partners are darley butler&co.ltd.,ambica international,jaalle genraltrading co.
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on orion pharma is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.